Skip to main content

Surgery or Surveillance for Asymptomatic Small Mucinous Pancreatic Head Cyst

  • Chapter
  • First Online:
  • 1118 Accesses

Part of the book series: Difficult Decisions in Surgery: An Evidence-Based Approach ((DDSURGERY))

Abstract

Mucinous pancreatic cysts are now common incidental findings with the increased use and higher resolution of modern cross-sectional imaging, and surgeons are faced with the challenge of identifying those patients with premalignant or malignant lesions from those lesions with little chance of ever impacting patient survival. The risks of selecting to observe mucinous cystic lesions should be balanced against the morbidity and mortality of pancreatic resection, particularly when located in the head of the pancreas. Currently, the criteria for resection are based mainly on morphologic features or abnormal cytological findings. Most of the controversy revolves around the management of small branch-duct IPMN, given its relatively low malignant potential, high prevalence in older patients, and tendency to appear in the head of the gland. Thick/enhanced cyst wall, dilation of the pancreatic duct and mural nodules are consistent predictors of malignancy, while size alone remains controversial and a subject for continued debate.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Brugge WR, Lauwers GY, Sahani D, et al. Cystic neoplasms of the pancreas. N Engl J Med. 2004;351:1218–26.

    Article  CAS  PubMed  Google Scholar 

  2. Crippa S, Salvia R, Warshaw AL, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity. Lessons from 163 resected patients. Ann Surg. 2008;247:571–9.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Nagula S, Kennedy T, Schattner MA, et al. Evaluation of cyst fluid CEA analysis in the diagnosis of mucinous cysts of the pancreas. J Gastrointest Surg. 2010;14:1997–2003.

    Article  PubMed  Google Scholar 

  4. Kobari M, Egawa S, Shibuya K, et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg. 1999;134:1131–6.

    Article  CAS  PubMed  Google Scholar 

  5. Torris B, Ponsot P, Paye F, et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol. 2000;24:1372–7.

    Article  Google Scholar 

  6. Doi R, Fujimoto K, Wada M, et al. Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery. 2002;132:80–5.

    Article  PubMed  Google Scholar 

  7. Matsumoto T, Aramaki M, Yada K, et al. Optimal management of the branch duct type intraductal papillary mucinous neoplasm of the pancreas. J Clin Gastroenterol. 2003;36:261–5.

    Article  PubMed  Google Scholar 

  8. Choi BS, Kim TK, Kim AY, et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangio-pancreatography and MR angiography. Korean J Radiol. 2003;4:157–62.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Kitagawa Y, Unger TA, Taylor S, et al. Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas. J Gastrointest Surg. 2003;7:12–9.

    Article  PubMed  Google Scholar 

  10. Sugiyama M, Izumisato Y, Abe N. Predictive factors for malignancy in intraductal papillary-mucinous tumors of the pancreas. Br J Surg. 2003;90:1244–9.

    Article  CAS  PubMed  Google Scholar 

  11. Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239:788–99.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Salvia R, Fernandez-del Castillo C, Basi C, et al. Main duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004;239:678–87.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Wada K, Takada T, Yasuda H, et al. Does “clonal progression” relate to the development of intraductal papillary mucinous tumors of the pancreas? J Gastrointest Surg. 2004;8:289–96.

    Article  PubMed  Google Scholar 

  14. Chari S, Yadav D, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology. 2002;123:1500–7.

    Article  PubMed  Google Scholar 

  15. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17–32.

    Article  PubMed  Google Scholar 

  16. Pelaez-Luna M, Chari ST, Smyrk TC, et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol. 2007;102:1759–64.

    Article  PubMed  Google Scholar 

  17. Tang RS, Weinberg B, Dawson DW, et al. Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol. 2008;6:815–9.

    Article  PubMed  Google Scholar 

  18. Nagai K, Doi R, Ito T, et al. Single-institution validation of the international consensus-guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Surg. 2009;16:353–8.

    Article  PubMed  Google Scholar 

  19. Tanaka M, Fernandez-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2012;12:183–97.

    Article  PubMed  Google Scholar 

  20. Kang MJ, Jang JY, Kim SJ, et al. Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. Clin Gastroenterol Hepatol. 2011;9:87–93.

    Article  PubMed  Google Scholar 

  21. Levy P, Jouannaud V, O’Toole D, et al. Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy. Clin Gastroenterol Hepatol. 2006;4:460–8.

    Article  PubMed  Google Scholar 

  22. Weinberg BM, Spiegel BM, Tomlinson JS, Farrell JJ. Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms. Gastroenterology. 2010;138:531–40.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Fritz S, Klauss M, Bergmann F, et al. Small (Sendai negative) branch-duct intraductal papillary mucinous neoplasms. Not harmless. Ann Surg. 2012;256:313–20.

    Article  PubMed  Google Scholar 

  24. Wong J, Weber J, Centeno BA, et al. High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound. J Gastrointest Surg. 2012;17:78–85.

    Article  PubMed  Google Scholar 

  25. Anand NJ, Sampath K, Wu BU. Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11:913–21.

    Article  PubMed  Google Scholar 

  26. Sahora K, Mino-Kenudson M, Brugge W, et al. Branch duct intraductal papillary mucinous neoplasms. Does cyst size change the tip of the scale? A critical analysis of the revised International Consensus Guidelines in a large single-institutional series. Ann Surg. 2013;258:466–75.

    Article  PubMed  Google Scholar 

  27. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s. Pathology, complications and outcomes. Ann Surg. 1997;226:248–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Fong Y, Gonen M, Rubin D, et al. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg. 2005;242:540–7.

    PubMed  PubMed Central  Google Scholar 

  29. Reddy RP, Smyrk TC, Zapiach M, et al. Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol. 2004;2:1026–31.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mitchell C. Posner .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Barreto, J.C., Posner, M.C. (2016). Surgery or Surveillance for Asymptomatic Small Mucinous Pancreatic Head Cyst. In: Millis, J., Matthews, J. (eds) Difficult Decisions in Hepatobiliary and Pancreatic Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach. Springer, Cham. https://doi.org/10.1007/978-3-319-27365-5_46

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27365-5_46

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27363-1

  • Online ISBN: 978-3-319-27365-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics